Hyman Phelps and McNamara
 
Firm Publicatons
 

The OxyContin Case - Something for Everyone
September 2007

The sellers of OxyContin recently agreed to settle government allegations of improper marketing, by entering into one of the largest monetary settlements ever entered into against a pharmaceutical company and its executives. Although the case dealt with controlled substances, it has broad implications for any company regulated by the Food and Drug Administration (FDA).

Click here to view the full FDLI Update Magazine article

If you have any questions regarding the above information, please contact:
John R. Fleder (202) 737-4580 jfleder@hpm.com